Literature DB >> 29351436

Therapeutic attenuation of the epithelial sodium channel with a SPLUNC1-derived peptide in airway diseases.

James F Collawn1,2,3, Rafal Bartoszewski4, Ahmad Lazrak, Sadis Matalon1,2,3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29351436      PMCID： PMC5866505          DOI： 10.1152/ajplung.00516.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN： 1040-0605            Impact factor:   5.464


× No keyword cloud information.
  47 in total

1.  Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis.

Authors:  J Y Choi; D Muallem; K Kiselyov; M G Lee; P J Thomas; S Muallem
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 2.  Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modifications.

Authors:  Michelle L McClure; Stephen Barnes; Jeffrey L Brodsky; Eric J Sorscher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

3.  Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lung.

Authors:  Ahmed Lazrak; Asta Jurkuvenaite; Lan Chen; Kim M Keeling; James F Collawn; David M Bedwell; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-08       Impact factor: 5.464

4.  Alpha(1)-antitrypsin inhibits epithelial Na+ transport in vitro and in vivo.

Authors:  Ahmed Lazrak; Izabella Nita; Devipriya Subramaniyam; Shipeng Wei; Weifeng Song; Hong-Long Ji; Sabina Janciauskiene; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-08       Impact factor: 6.914

5.  The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.

Authors:  M Mall; M Bleich; R Greger; R Schreiber; K Kunzelmann
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

6.  Evidence for reduced Cl- and increased Na+ permeability in cystic fibrosis human primary cell cultures.

Authors:  R C Boucher; C U Cotton; J T Gatzy; M R Knowles; J R Yankaskas
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

7.  The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia.

Authors:  Mark J Turner; Elizabeth Matthes; Arnaud Billet; Amy J Ferguson; David Y Thomas; Scott H Randell; Lawrence E Ostrowski; Kathy Abbott-Banner; John W Hanrahan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-06       Impact factor: 5.464

8.  SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage.

Authors:  Agustin Garcia-Caballero; Julia E Rasmussen; Erol Gaillard; Michael J Watson; John C Olsen; Scott H Donaldson; M Jackson Stutts; Robert Tarran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-18       Impact factor: 11.205

9.  Inter-α-inhibitor blocks epithelial sodium channel activation and decreases nasal potential differences in ΔF508 mice.

Authors:  Ahmed Lazrak; Asta Jurkuvenaite; Emily C Ness; Shaoyan Zhang; Bradford A Woodworth; Marianne S Muhlebach; Vandy P Stober; Yow-Pin Lim; Stavros Garantziotis; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

10.  Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats.

Authors:  Katherine L Tuggle; Susan E Birket; Xiaoxia Cui; Jeong Hong; Joe Warren; Lara Reid; Andre Chambers; Diana Ji; Kevin Gamber; Kengyeh K Chu; Guillermo Tearney; Li Ping Tang; James A Fortenberry; Ming Du; Joan M Cadillac; David M Bedwell; Steven M Rowe; Eric J Sorscher; Michelle V Fanucchi
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.